IN PARTNERSHIP WITH
This FT Digital Dialogue on Innovative Clinical Research Strategies, organised in partnership with ICON plc, discussed how to design and run more resilient trials in an uncertain world, where the need to decentralise is driving investment in new technology solutions and changing the pharma R&D landscape.
SPEAKERS
KEY TALKING POINTS
How is trial design evolving in terms of data collection, safety reporting, tracking and other processes?
What are some of the challenges around moving to remote study management and off-site monitoring?
What can be done to manage the risks and consequences of trials being suspended and re-started?
How could new approaches to clinical trial management affect access to patient populations and how can direct patient support services be improved?
How can relationships with regulators, patients and other stakeholders evolve to accommodate new processes and solutions?
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice